Dietary intake of n-3 PUFAs modifies the absorption, distribution and bioavailability of fatty acids in the mouse gastrointestinal tract

Table 1 n-3 polyunsaturated fatty acids (PUFAs) and n-6 PUFAs content (in% of total FA) of the 17 intestinal segments

ISN	Control group		n-3 group		n-6 group
	n-3 PUFAs	n-6 PUFAs	n-3 PUFAs	n-6 PUFAs	n-3 PUFAs	n-6 PUFAs
1	2.68 ± 0.34	30.56 ± 0.84	16.27 ± 1.10	21.83 ± 1.83	1.94 ± 0.66	49.60 ± 1.14
2	2.42 ± 0.25	28.30 ± 1.86	15.84 ± 1.61	20.21 ± 1.51	1.38 ± 0.42	48.51 ± 6.60
3	1.90 ± 0.48	25.68 ± 7.88	14.06 ± 2.39	19.56 ± 1.73	1.17 ± 0.18	49.69 ± 2.82
4	2.38 ± 0.42	29.54 ± 5.54	15.82 ± 2.02	20.41 ± 2.91	1.13 ± 0.40	46.98 ± 5.08
5	2.09 ± 0.76	26.38 ± 7.62	15.67 ± 1.71	19.50 ± 2.32	1.00 ± 0.45	39.51 ± 5.79
6	2.77 ± 0.16	27.65 ± 7.21	13.24 ± 3.65	17.49 ± 2.28	1.53 ± 0.62	43.92 ± 9.39
7	1.76 ± 0.33	19.35 ± 1.95	13.52 ± 2.78	18.31 ± 1.76	1.79 ± 0.74	39.39 ± 5.11
8	2.14 ± 0.76	21.46 ± 5.63	6.10 ± 2.73	15.93 ± 2.53	1.92 ± 1.14	34.37 ± 8.04
9	2.79 ± 1.99	23.94 ± 10.2	5.90 ± 2.24	15.13 ± 2.37	3.06 ± 0.76	35.52 ± 5.08
10	1.76 ± 0.87	17.13 ± 5.65	12.80 ± 5.75	18.03 ± 2.52	1.98 ± 1.21	36.48 ± 7.75
11	2.81 ± 1.27	18.91 ± 5.84	13.13 ± 2.90	16.45 ± 1.99	0.81 ± 0.10	29.23 ± 3.69
12	1.14 ± 0.36	12.77 ± 2.28	9.38 ± 3.98	15.10 ± 2.99	0.67 ± 0.05	30.22 ± 4.86
13	1.98 ± 0.86	13.51 ± 2.33	5.62 ± 1.49	14.49 ± 3.80	1.31 ± 0.18	26.16 ± 1.50
14	1.76 ± 0.86	15.34 ± 2.18	5.76 ± 0.77	16.51 ± 3.77	0.49 ± 0.09	30.98 ± 1.97
15	2.25 ± 1.50	14.83 ± 4.98	5.09 ± 2.18	19.14 ± 3.44	1.17 ± 0.26	27.79 ± 2.63
16	2.83 ± 0.03	11.36 ± 1.44	7.56 ± 1.51	8.22 ± 2.36	0.71 ± 0.33	25.94 ± 2.35
17	2.34 ± 0.09	10.51 ± 2.77	5.38 ± 1.56	10.70 ± 4.96	0.81 ± 0.16	24.25 ± 2.29

Values are \( \overline{x}\kern0.5em \pm \kern0.5em s \), as for n-3 PUFA3, there were no significance between Control and n-6 groups (P > 0.05 by ANOVA); and there were significant differences between n-3 and Control or n-6 groups (P < 0.05 by ANOVA) for n-3 PUFAs, as well as among Control, n-3 and n-6 groups (P < 0.05 by ANOVA) for n-6 PUFAs